UBS

Dexin China Holdings Co has worked hard to court bond investors and establish its name this year. The move paid off on Thursday, when the issuer grabbed its first single digit bond coupon.

JD Health International is set to close the international investor book for its up-to HK$27bn ($3.5bn) IPO a day early, according to a source familiar with matter.

Evergrande Property Services Group, the property management arm of one China’s most debt-laden developers, wrapped up its IPO toward the bottom of price guidance after relying largely on Chinese investors.

European banks are running out of ways of selling senior bonds at positive yields. A near-miss from Svenska Handelsbanken this week was enough to convince the market that it’s only a matter of time before an issuer breaks the 0% barrier, write Tyler Davies and Frank Jackman.

Rating: A3/A/AA

MSCI picks up Nick Mihic — Algomi co-founder Stuart Taylor joins MUFG — Vinod Vasan changes roles at UBS

JD Health International launched 2020’s largest healthcare listing this week, hitting the road to raise up to HK$27bn ($3.5bn) in a Hong Kong IPO. The issuer blends healthcare and technology, two of the hottest sectors in the IPO market this year. It covered the deal multiple times on the first day. Jonathan Breen reports.

Evergrande Property Services Group, the property management arm of embattled developer Evergrande Group, was wrapping up its Hong Kong IPO on a strong note as GlobalCapital Asia went press, with proceeds of up to HK$15.8bn ($2bn) looking within reach.

Svenska Handelsbanken sailed very close negative yield territory when it printed a €500m seven year green senior non-preferred deal on Wednesday.

China Hongqiao Group, the world’s largest aluminium producer, raised HK$1.94bn ($249.9m) on Tuesday after increasing the size of a top-up share placement.

JD Health International has hit the road with an up-to HK$27bn ($3.5bn) Hong Kong IPO, set to be the largest primary listing in the city this year.

Shui On Land tapped its 5.75% 2023 bond on Tuesday for an additional $200m, bringing the unrated deal to $500m.